Toward a Shared Vision for Cancer Genomic Data
Open accessThe DOI matches its Crossref record; 6 of the 7 references it cites were found in a registry or an index.
Abstract
This FAIRsharing record describes: The National Cancer Institute’s (NCI’s) Genomic Data Commons (GDC) is a data sharing The National Cancer Institute's Genomic Data Commons (GDC) was created to promote precision medicine in oncology. It supports the import and standardization of genomic and clinical data from cancer research programs. The GDC contains NCI-generated data from some of the largest and most comprehensive cancer genomic datasets, including The Cancer Genome Atlas (TCGA) and Therapeutically Applicable Research to Generate Effective Therapies (TARGET). For the first time, these datasets have been harmonized using a common set of bioinformatics pipelines, so that the data can be directly compared. As a growing knowledge system for cancer, the GDC also enables researchers to submit data, and harmonizes these data for import into the GDC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Again, the MEKi bypass resistance was strongly correlated with the SRC activation/dasatinib sensitivity, the EMT-like stemness and the CMS4 subtype (see Fig. 6 and Fig. 7 as well as Additional File 3_Fig S5 and Fig S6).”
From An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy (2022) · cites this paper as [47]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Discovery and saturation analysis of cancer genes across 21 tumour types
Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096
Combined Vemurafenib and Cobimetinib in BRAF -Mutated Melanoma
Larkin, J., Ascierto, P. A., Dréno, B., Atkinson, V., Liszkay, G., Maio, M., Mandalà, M., Demidov, L., Stroyakovskiy, D., Thomas, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408868 · Cited by 2,068
Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
Shaw, A. T., Ou, S.-H. I., Bang, Y.-J., Camidge, D. R., Solomon, B. J., Salgia, R., Riely, G. J., Varella-Garcia, M., Shapiro, G. I., Costa, D. B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406766 · Cited by 1,964
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
Wilson, W. H., Young, R. M., Schmitz, R., Yang, Y., Pittaluga, S., Wright, G., Lih, C.-J., Williams, P. M., Shaffer, A. L., Gerecitano, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3884 · Cited by 1,113
Self-citationSharing Clinical Trial Data: A Proposal From the International Committee of Medical Journal Editors
Taichman, D. B., Backus, J., Baethge, C., Bauchner, H., de Leeuw, P. W., Drazen, J. M., Fletcher, J., Frizelle, F. A., Groves, T., Haileamlak, A., et al. (2016) · JAMA · doi:10.1001/jama.2015.18164 · Cited by 254
Sharing Clinical Trial Data — A Proposal from the International Committee of Medical Journal Editors
Taichman, D. B., Backus, J., Baethge, C., Bauchner, H., de Leeuw, P. W., Drazen, J. M., Fletcher, J., Frizelle, F. A., Groves, T., Haileamlak, A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejme1515172 · Cited by 190
Cited by
Items 701–800 of 1,004
Recent advances in targeting protein degradation for tumor immunotherapy
Li, S., Jin, Y., Wu, H., Yuan, H., & Zhao, J. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01765-4 · Cited by 14
“5 According to data from the National Cancer Institute’s Genome Data Commons [234], the expression levels of the 10 E3 ligases currently used in the PROTAC field vary significantly across different tumors.”
Zheng, B., Shen, S., Wong, K., Gong, Z., Sun, W., Ni, X., Wang, J., Hu, M., Liu, H., Ni, X., et al. (2021) · Journal of Surgical Oncology · doi:10.1002/jso.26399 · Cited by 14
“gov/).(26) The raw data were normalized to transcripts per million (TPM) values as previously described.”
MethodPallotta, S., Cascianelli, S., & Masseroli, M. (2022) · BMC Bioinformatics · doi:10.1186/s12859-022-04648-4 · Cited by 14
“LQ <- apply(rawMatrix, 2, function(x) summary(x)[2]) kept <- which(LQ > 0) dataset <- rawData[, kept]”
Dammak, S., Cecchini, M. J., Breadner, D. A., & Ward, A. D. (2023) · Journal of medical imaging · doi:10.1117/1.jmi.10.1.017502 · Cited by 14
“21,23 We then set the label as TMB-high for all tumors with ≥ 10 mutations/Mb and TMB-low for all other tumors, in accordance with the threshold used for recommendation of immunotherapy.”
BackgroundMOPA: An integrative multi-omics pathway analysis method for measuring omics activity
Jeon, J., Han, E., & Jung, I. (2023) · PLoS ONE · doi:10.1371/journal.pone.0278272 · Cited by 14
“A tutorial using the TCGA-COAD colon cancer data is also available at the github repository.”
MethodInfluentialThakur, A., Gizzio, J., & Levy, R. M. (2024) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c08097 · Cited by 14
Dasgupta, N., Thakur, B. K., Chakraborty, A., & Das, S. (2018) · Nutrition and Cancer · doi:10.1080/01635581.2018.1540715 · Cited by 14
Future Approaches to Precision Oncology–Based Clinical Trials
Mittra, A., & Moscow, J. A. (2019) · The Cancer Journal · doi:10.1097/ppo.0000000000000383 · Cited by 14
Common polymorphic inversions at 17q21.31 and 8p23.1 associate with cancer prognosis
Ruiz-Arenas, C., Cáceres, A., Moreno, V. R., & González, J. R. (2019) · Human Genomics · doi:10.1186/s40246-019-0242-2 · Cited by 14
“We obtained TCGA SNP data in Birdseed format from NCI Genomic Data Commons (GDC) legacy archive [13].”
Methoddecorate: differential epigenetic correlation test
Hoffman, G. E., Bendl, J. M., Girdhar, K., & Roussos, P. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa067 · Cited by 14
Mitchel, J., Chatlin, K., Li, T., & Wang, M. D. (2019) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm47256.2019.8983243 · Cited by 14
“Multi-omics data from breast cancer patients has been made978-1-7281-1867-3/19/$31.00 ©2019 IEEE publicly available from The Cancer Genome Atlas (TCGA), a joint project between the National Cancer Institute and the National Human Genome Research Institute [7].”
BackgroundInfluentialIdentifying Gene Signatures for Cancer Drug Repositioning Based on Sample Clustering
Wang, F., Ding, Y., Lei, X., Liao, B., & Wu, F. (2020) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2020.3019781 · Cited by 14
Genetic and immunologic features of recurrent stage I lung adenocarcinoma
Kratz, J. R., Li, J. Z., Tsui, J. L., Lee, J. C., Ding, V. W., Rao, A. A., Mann, M. J., Chan, V., Combes, A. J., Krummel, M. F., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-02946-0 · Cited by 14
Tiberti, M., Leo, L. D., Vistesen, M. V., Kuhre, R. S., Cecconi, F., Zio, D. D., & Papaleo, E. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05318-2 · Cited by 14
“Resources as Genomic Data Commons (GDC) [1] store information from different studies from cancer genomic initiatives, such as The Cancer Genome Atlas [2] and the Therapeutically Applicable Research To Generate Effective Treatments (TARGET) initiative (https://ocg.cancer.gov/programs/target).”
BackgroundChandler, M. R., Keene, K. S., Tuomela, J. M., Forero, A., Desmond, R. A., Vuopala, K. S., Harris, K. W., Merner, N. D., & Selander, K. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183832 · Cited by 14
Choi, J., Tarnouskaya, A., Nesdoly, S., Topouza, D. G., Koti, M., & Duan, Q. (2020) · BMC Cancer · doi:10.1186/s12885-020-06922-1 · Cited by 14
“We retrieved 587 high-grade serous ovarian carcinoma (HGSOC) patients with available clinical data from the Cancer Genome Atlas (TCGA) Genomic Data Commons (GDC) portal [21] using the TCGAbiolinks R/Bioconductor package [22].”
MethodLawler, M., & Maughan, T. (2017) · The New Bioethics · doi:10.1080/20502877.2017.1314883 · Cited by 14
Evaluation of Somatic Mutations in Solid Metastatic Pan-Cancer Patients
Roosan, M. R., Mambetsariev, I., Pharaon, R. R., Fricke, J., Baroz, A. R., Chao, J., Chen, C., Nasser, M. W., Chirravuri‐Venkata, R., Jain, M., et al. (2021) · Cancers · doi:10.3390/cancers13112776 · Cited by 14
“We also compared our cohort to the mutation case frequencies from the Genomic Data Commons (GDC) and 500 adult patients with solid metastatic tumors [10,11].”
ResultRevealing the grammar of small RNA secretion using interpretable machine learning
Zirak, B., Naghipourfar, M., Saberi, A., Pouyabahar, D., Zarezadeh, A., Luo, L., Fish, L., Huh, D., Navickas, A., Sharifi‐Zarchi, A., et al. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100522 · Cited by 13
“Figure S1F displays similarly strong performance metrics for miRNAs (microRNAs), small nucleolar RNAs, small cytoplasmic RNAs, and tRNAs (transfer RNAs), indicating that ExoGRU is capable of accurately predicting small RNA secretion across all these classes.”
Youth, E. H. H., Famili-Youth, A., Yang, D., Siddique, A., Wu, E. Y., Liu, W., Resnick, M. B., Chen, Q., & Brodsky, A. S. (2025) · BMC Cancer · doi:10.1186/s12885-025-13641-y · Cited by 13
“Batch-corrected, normalized RNA-Seq-derived RSEM values for breast invasive carcinoma (BRCA, n = 1,095 samples) and pancreatic adenocarcinoma (PAAD, n = 178 samples) TCGA cohorts were down-loaded from the NIH National Cancer Institute Genomic Data Commons [27, 28].”
Börcsök, J., Gopaul, D., Devesa-Serrano, D., Mooser, C., Jonsson, N., Cagiada, M., Stormoen, D. R., Ataya, M. N., Guercio, B. J., Kaimakliotis, H. Z., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci186688 · Cited by 13
“The WES normal and tumor bam files were downloaded from the Genomic Data Commons (GDC) data portal (36) (https://portal.gdc.cancer.gov/).”
Espiritu, D., Sheng, Y., Peng, Y., Ostroverkhova, D. S., Li, S., Landsman, D., Aristizabal, M. J., & Panchenko, A. R. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf899 · Cited by 13
“Genetic and clinical data were gathered from patients in The Cancer Genome Atlas, Multiple Myeloma Research Foundation CoMMpass, Human Cancer Model Initiative, Count Me In, and Clinical Proteomic Tumor Analysis Consortium programs through the Genomic Data Commons (GDC) [ 31 ].”
Daza-Cajigal, V., Albuquerque, A. S., Pearson, J. F., Hinley, J., Mason, A. S., Stahlschmidt, J., Thrasher, A. J., Mishra, V., Southgate, J., & Burns, S. O. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02065 · Cited by 13
“Analysis of the muscle invasive bladder cancer (BLCA) cohort from The Cancer Genome Atlas (TCGA) (20) identified 31 different JAK1 variants in 25/412 TCGA BLCA samples, including single nucleotide variants predicted to alter JAK1 protein function and non-sense/frameshift variants predicted to impair JAK1 signaling (Fi…”
BackgroundMethodInfluentialHPV-EM: an accurate HPV detection and genotyping EM algorithm
Inkman, M. J., Jayachandran, K., Ellis, T. M., Ruiz, F., McLellan, M. D., Miller, C. A., Wu, Y., Ojesina, A. I., Schwarz, J. K., & Zhang, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-71300-7 · Cited by 13
A Nomogram Combining a Four-Gene Biomarker and Clinical Factors for Predicting Survival of Melanoma
Zhang, C., Dang, D., Wang, Y., & Cong, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.593587 · Cited by 13
“First, we randomly divided 449 melanoma patients with RNA sequencing data and complete survival data from TCGA cohort into the training set I (n = 224) and validation set I (n = 225) (Table S1).”
InfluentialGroth, T., Gunawan, R., & Neelamegham, S. (2021) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.17.119 · Cited by 13
Morales, F., Pérez, P., Tapia, J. C., Lobos‐González, L., Herranz, J. M., Guevara, F., de Santiago, P. R., Palacios, E., Andaur, R., Sagredo, E. A., et al. (2022) · Gene · doi:10.1016/j.gene.2022.146246 · Cited by 13
Meduri, E., Breeze, C. E., Marando, L., Richardson, S. E., & Huntly, B. J. P. (2022) · iScience · doi:10.1016/j.isci.2022.105622 · Cited by 13
Sharma, A. K., Singh, P. K., Jha, R., Almatroodi, S. A., Alrumaihi, F., Rahmani, A. H., Alharbi, H. O., Dohare, R., & Syed, M. A. (2023) · Scientific Reports · doi:10.1038/s41598-023-43484-1 · Cited by 13
Takamatsu, S., Hillman, R. T., Yoshihara, K., Baba, T., Shimada, M., Yoshida, H., Kajiyama, H., Oda, K., Mandai, M., Okamoto, A., et al. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02837-x · Cited by 14
“We obtained multi-omics datasets of The Cancer Genome Atlas (TCGA) project for high-grade serous ovarian cancer (TCGA-OV) [49] and uterine corpus endometrial cancer (TCGA-UCEC) [50] from the GDC portal [51] (Supplementary Table 3).”
Zhang, H., Cao, D., Chen, Z., Zhang, X., Chen, Y., Sessions, C., Cruchaga, C., Payne, P., Li, G., Province, M. A., et al. (2024) · Bioinformatics Advances · doi:10.1093/bioadv/vbae151 · Cited by 13
“The datasets were generated and publicly accessible (Grossman et al. 2016, Goldman et al. 2020) to characterize and understand the genomic alterations and molecular profiles of > 30 cancer types/subtypes.”
MethodInfluentialLi, F., Hu, H., Li, L., Ding, L., Lu, Z., Mao, X., Wang, R., Luo, W., Lin, Y., Li, Y., et al. (2024) · Biology Direct · doi:10.1186/s13062-024-00576-w · Cited by 13
“Six independent public datasets were sourced from the Genomic Data Commons ( h t t p s : / / p o r t a l . g d c . c a n c e r . g o v / ) [36], Proteomic Data Commons ( h t t p s : / / p d c . c a n c e r . g o v / p d c / ) , Gene Expression Omnibus ( h t t p s : / / w w w . n c b i . n l m . n i…”
Chromatic: WebAssembly-Based Cancer Genome Viewer
Finney, R., & Meerzaman, D. M. (2018) · Cancer Informatics · doi:10.1177/1176935118771972 · Cited by 13
A TOP2A‑derived cancer panel drives cancer progression in papillary renal cell carcinoma
Ye, M., He, Z., Dai, W., Li, Z., Chen, X., & Liu, J. (2018) · Oncology Letters · doi:10.3892/ol.2018.9179 · Cited by 13
DNMT3A co-mutation in an IDH1-mutant glioblastoma
Fomchenko, E. I., Erson-Omay, Z., Zhao, A., Bindra, R. S., Huttner, A. J., Fulbright, R. K., & Moliterno, J. A. (2019) · Molecular Case Studies · doi:10.1101/mcs.a004119 · Cited by 13
“Analysis of the TCGA database identified eight DNMT3A mutations in six TCGA-GBM patients and 10 DNMT3A mutations in 10 TCGA-LGG patients in residues other than 904; two TCGA-GBM patients carried two DNMT3A mutations each, similar to AML patients (Grossman et al. 2016).”
BackgroundSecurity and privacy solutions for smart healthcare systems
Lü, Y., & Sinnott, R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819043-2.00008-3 · Cited by 13
“For clinical research, it is necessary to obtain approvals from cancer patients or their families before using their genomic data (Grossman et al., 2016).”
BackgroundInvolvement of NEK2 and its interaction with NDC80 and CEP250 in hepatocellular carcinoma
Zeng, L., Fan, X., Wang, X., Deng, H., Zhang, X., Zhang, K., He, S., Li, N., Han, Q., & Liu, Z. (2020) · BMC Medical Genomics · doi:10.1186/s12920-020-00812-y · Cited by 13
“Survival analyses by TCGA database Clinical data of HCC patients were downloaded from TCGA database [30] and the effects of different mRNA expression levels of NEK2 and the genes of NEK2 interacting proteins on prognosis of HCC patients were investigated.”
Lasham, A., Knowlton, N. S., Mehta, S. Y., Braithwaite, A. W., & Print, C. G. (2021) · Cancers · doi:10.3390/cancers13071531 · Cited by 13
“In order to determine whether this was a feature of TP53 intron 4 splice mutations, we examined RNA-seq data from the TCGA BRCA cohort [20,21].”
MethodRuff, G. L., Murphy, K. E., Smith, Z. R., Vertino, P. M., & Murphy, P. J. (2021) · BMC Cancer · doi:10.1186/s12885-021-09077-9 · Cited by 13
“Availability of data and materials The ATAC-Seq datasets of chromatin accessibility, the gene expression datasets, tumor stage data, and IHC subtype data are all available from TCGA-BRCA project in the NCI’s GDC [16] (https:// portal.”
MethodInfluentialHamel, K. M., King, C. T., Cavalier, M., Liimatta, K. Q., Rozanski, G. L., King, T. A., Lam, M., Bingham, G. C., Byrne, C. E., Xing, D., et al. (2022) · Stem Cells and Development · doi:10.1089/scd.2021.0279 · Cited by 13
“Ductal and lobular neoplasms were selected from the case set of The Cancer Genome Atlas (TCGA)-Breast Cancer Gene (BRCA) project (phs000178.v11.p8) derived from the National Institute of Health (NIH) Genomic Data Commons (GDC) Data Portal [49].”
Ruzinova, M. B., Ma, C., Brunt, E. M., Goss, C. W., Vachharajani, N. A., Chapman, W. C., & Liu, T. (2022) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001990 · Cited by 13
“00001 Hepatitis B 18 (8) 102 (25) Hepatitis C 94 (41) 53 (13)”
A scale and region-enhanced decoding network for nuclei classification in histology image
Xiao, S., Qu, A., Zhong, H., & He, P. (2023) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2023.104626 · Cited by 13
Mutations in the coat complex II component SEC23B promote colorectal cancer metastasis
Yang, C., Chen, N., Li, X., Lü, D., Hou, Z., Li, Y., Jin, Y., Gu, J. F., & Yin, Y. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2358-7 · Cited by 13
Images in Space and Time: Real Big Data in Healthcare
Badr, E. (2021) · ACM Computing Surveys · doi:10.1145/3453657 · Cited by 13
“edu) [34] Microscopy Inception Lung cancer subtypes classification The Cancer Genome Atlas (TCGA) [64] [203] MRI 3D DenseNet Breast cancer classification Retrospective study [121] X-ray VGG-16 with an attention layer Bone age prediction Radiological Society of North America (RSNA) (https://www.”
BackgroundBattistella, E., Vakalopoulou, M., Sun, R., Estienne, T., Lerousseau, M., Nikolaev, S. I., Andres, É. A., Carré, A., Niyoteka, S., Robert, C., et al. (2021) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2021.3123910 · Cited by 13
“In this study, we based our experiments on The Cancer Genome Atlas (TCGA) dataset [33].”
MethodGenomicDataCommons: a Bioconductor Interface to the NCI Genomic Data CommonsPreprint
Morgan, M. T., & Davis, S. R. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/117200 · Cited by 13
“To address the needs of the cancer community to access, query, and utilize these cancer-related data resources, the NCI has developed the Genomic Data Commons (GDC, Grossman et al. 2016).”
MethodCancers adapt to their mutational load by buffering protein misfolding stressPreprint
Tilk, S., Frydman, J., Curtis, C. N., & Petrov, D. A. (2024) · eLife · doi:10.7554/elife.87301 · Cited by 13
Decoding Drug Response With Structurized Gridding Map-Based Cell Representation
Yin, J., Zhang, H., Sun, X., You, N., Mou, M., Lu, M., Pan, Z., Li, F., Li, H., Zeng, S., et al. (2023) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2023.3342280 · Cited by 12
“These patient-drug combinations involved 1,405 different patients and 133 unique drugs covering 29 cancer types, and raw genomic expression data of patients were obtained from the NCI Genomic Data Commons portal [85].”
Zalli, D., Mai, Z., Ferati, E., Ramaj, A., Bregu, R., & Pranjol, M. Z. I. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_413-1 · Cited by 12
RPS24 alternative splicing is a marker of cancer progression and epithelial-mesenchymal transition
Park, J., Nam, D. H., Kim, D., & Chung, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-63976-y · Cited by 12
“This count served as a measure of the overall expression level of the RPS24 gene specifically within that particular sample.”
BackgroundTruesdell, P. F., Chang, J. K., Villa, D. C., Dai, M., Zhao, Y., McIlwain, R., Young, S., Hiley, S. L., Craig, A. W., & Babak, T. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00673-z · Cited by 12
Navigating Through Whole Slide Images With Hierarchy, Multi-Object, and Multi-Scale Data
Tran, M., Wagner, S., Weichert, W., Matek, C., Boxberg, M., & Peng, T. (2025) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2025.3532728 · Cited by 12
“It consists of 38 sparsely labeled colorectal adenocarcinoma (COAD) WSIs from The Cancer Genome Atlas Colon (TCGA) [19], [20], [21] with 31 tissue classes at different scales.”
Decoding the NRF2–NOTCH Crosstalk in Lung Cancer—An Update
Sparaneo, A., Torrisi, F., D’Angeli, F., Giurdanella, G., Bravaccini, S., Muscarella, L. A., & Fabrizio, F. P. (2025) · Antioxidants · doi:10.3390/antiox14060657 · Cited by 12
Analysis and visualization of linked molecular and clinical cancer data by using Oncoscape
McFerrin, L. G., Zager, M. A., Zhang, J., Krenn, G., McDermott, R., Horse-Grant, D., Silgard, E. T., Colevas, K., Shannon, P. T., Bolouri, H., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0208-7 · Cited by 12
Visual Analytics for Hypothesis-Driven Exploration in Computational Pathology
Corvò, A., Caballero, H. S. G., Westenberg, M. A., van Driel, M. A., & van Wijk, J. J. (2020) · IEEE Transactions on Visualization and Computer Graphics · doi:10.1109/tvcg.2020.2990336 · Cited by 12
Interaction with the CCT chaperonin complex limits APOBEC3A cytidine deaminase cytotoxicity
Green, A. M., DeWeerd, R. A., O’Leary, D. R., Hansen, A. R., Hayer, K. E., Kulej, K., Dineen, A. S., Szeto, J. H., Garcia, B. A., & Weitzman, M. D. (2021) · EMBO Reports · doi:10.15252/embr.202052145 · Cited by 12
“0; Grossman et al, 2016).”
Song, S., Liu, S., Wei, Z., Jin, X., Mao, D., He, Y., Li, B., & Zhang, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.726716 · Cited by 12
Giner-Calabuig, M., Leon, S. D., Wang, J., Fehlmann, T. D., Ukaegbu, C. I., Gibson, J. A., Alustiza, M., Picó, M. D., Alenda, C., Herráiz, M., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01754-1 · Cited by 12
“Clinical and demographic data for TCGA cases were obtained from their data repository(21).”
MethodIdentification, function, and biological relevance of POGLUT2 and POGLUT3
Williamson, D. B., & Haltiwanger, R. S. (2022) · Biochemical Society Transactions · doi:10.1042/bst20210850 · Cited by 12
The DNA methylation landscape of five pediatric-tumor types
Parker, A., Quinteros, B., & Piccolo, S. (2022) · PeerJ · doi:10.7717/peerj.13516 · Cited by 12
“To identify primary status and patient sex, we downloaded clinical variables from the Genomic Data Commons portal (Pugh et al., 2013; Grossman et al., 2016; Gadd et al., 2017) by going to the project homepage (such as https://portal.”
MethodTonmoy, M. I. Q., Fariha, A., Hami, I., Kar, K., Reza, H. A., Bahadur, N. M., & Hossain, M. S. (2022) · Scientific Reports · doi:10.1038/s41598-022-13381-0 · Cited by 12
Barbari, S. R., Beach, A. K., Markgren, J. G., Parkash, V., Moore, E. A., Johansson, E., & Shcherbakova, P. V. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac602 · Cited by 12
“Of note, although the mutator effect of pol2-V426L in MMR-deficient background provides long-awaited evidence that this variant affects replication fidelity in vivo , tumors carrying the POLE-V411L allele are microsatellite stable and thus presumed to have functional MMR (18,42,43).”
Karihtala, P., Porvari, K., Roininen, N., Voutilainen, S., Mattson, J., Heikkilä, P., Haapasaari, K., & Selander, K. S. (2022) · Oncogenesis · doi:10.1038/s41389-022-00427-1 · Cited by 12
“We compared the sequencing results with previously published mutational spectra of IDC and pancreatic NET (PNET) cases from The Cancer Genomic Atlas (TCGA) [11, 12].”
BackgroundMethodResultInfluentialSelf-omics: A Self-supervised Learning Framework for Multi-omics Cancer Data
Hashim, S., Nandakumar, K., & Yaqub, M. K. (2022) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789811270611_0025 · Cited by 12
Zhao, H., Jia, P., Nanding, K., Wu, M., Bai, X., Morigen, M., & Fan, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1046269 · Cited by 12
“LPA signaling pathway induces DNA synthesis in HGSOC cells GSEA was performed from the TCGA ovarian cancer database on the LinkedOmics website to evaluate the effects of LPA-activated geminin expression in HGSOC development.”
MethodInfluentialXulu, K. R., Nweke, E. E., & Augustine, T. N. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1087432 · Cited by 12
“Databases such as the NCI Genomic Data Commons (GDC) provide a view into the genomic landscape of breast cancer (Figure 2) (Grossman et al., 2016).”
BackgroundMethodCytosolic DNA sensor AIM2 promotes KRAS ‐driven lung cancer independent of inflammasomes
Alanazi, M. A., Weng, T., McLeod, L., Gearing, L. J., Smith, J. A., Kumar, B., Saad, M. I., & Jenkins, B. J. (2024) · Cancer Science · doi:10.1111/cas.16171 · Cited by 12
“32 Counts were processed and differential expression analysis was per - formed using the edgeR package 33 to create a DGEList object, and gene annotation information was obtained using the Homo.sapiens package.”
MethodLiu, D. D., & Zhang, L. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0125-5 · Cited by 12
Ungerleider, N., & Flemington, E. K. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2865-7 · Cited by 12
Troiano, G., Caponio, V. C. A., Botti, G., Aquino, G., Losito, S., Pedicillo, M. C., Zhurakivska, K., Arena, C., Ciavarella, D., Mastrangelo, F., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010121 · Cited by 12
Montesino, B., Steenackers, A., Lozano, J. M., Young, G. D., Hu, N., Sackstein, R., & Chandler, K. B. (2021) · Glycobiology · doi:10.1093/glycob/cwab131 · Cited by 12
Haisheng, Z., Tao, Y., Huang, Q., Chen, Z., Jiang, L., Yan, H., Zhong, J., & Liang, L. (2021) · FEBS Open Bio · doi:10.1002/2211-5463.13348 · Cited by 12
HeartBioPortal: An Internet-of-Omics for Human Cardiovascular Disease Data
Khomtchouk, B. B., Vand, K. A., Koehler, W. C., Tran, D.-T. T., Middlebrook, K., Sudhakaran, S., Nelson, C. S., Gozani, O., & Assimes, T. L. (2019) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.118.002426 · Cited by 12
Alizadeh, M. A., Schledwitz, A., Cheng, K., & Raufman, J. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.857563 · Cited by 12
Jiménez-Rodríguez, B., Alba-Bernal, A., López-López, E., Quirós-Ortega, M. E., Carbajosa, G., Garrido-Aranda, A., Álvarez, M., Godoy-Ortíz, A., Queipo‐Ortuño, M. I., Vicioso, L., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010146 · Cited by 12
Ha, Y. J., Shin, Y. J., Tak, K. H., Park, J., Kim, J., Lee, J. L., Yoon, Y. S., Kim, C. W., Kim, S., & Kim, J. C. (2023) · Cancer Medicine · doi:10.1002/cam4.5675 · Cited by 12
Mohl, D. A., Lagies, S., Zodel, K., Zumkeller, M., Peighambari, A., Ganner, A., Plattner, D. A., Neumann‐Haefelin, E., Adlesic, M., Frew, I. J., et al. (2023) · Cells · doi:10.3390/cells12081102 · Cited by 12
Marino, G. B., Ngai, M., Clarke, D. J. B., Fleishman, R. H., Deng, E. Z., Xie, Z., Ahmed, N., & Ma’ayan, A. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad399 · Cited by 12
The NCI Imaging Data Commons as a platform for reproducible research in computational pathology
Schacherer, D. P., Herrmann, M. D., Clunie, D., Höfener, H., Clifford, W., Longabaugh, W. J. R., Pieper, S., Kikinis, R., Fedorov, A., & Homeyer, A. (2023) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2023.107839 · Cited by 11
“Images included in the IDC are often accompanied by other types of data available within other components of CRDC, such as the Genomic Data Commons [54] or the Proteomic Data Commons [55].”
MethodBuilding trans-omics evidence: using imaging and ‘omics’ to characterize cancer profiles
Srivastava, A., Kulkarni, C., Mallick, P., Huang, K., & Machiraju, R. (2017) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789813235533_0035 · Cited by 12
Qiu, J., Shi, D., Liu, X., Zheng, X., Wang, L., & Li, Q. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27440 · Cited by 12
“There were totally 412 cases of the urothelial bladder carcinoma from TCGA project in the GDC data portal (Grossman et al., 2016).”
BackgroundAssociating somatic mutations to clinical outcomes: a pan-cancer study of survival time
Little, P., Lin, D. Y., & Sun, W. (2019) · Genome Medicine · doi:10.1186/s13073-019-0643-9 · Cited by 13
Neums, L., Meier, R. L., Koestler, D. C., & Thompson, J. A. (2019) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789811215636_0037 · Cited by 12
Akshaya, R. L., Akshaya, N., & Selvamurugan, N. (2020) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2020.107386 · Cited by 12
Hiemer, S. E., Jatav, S., Jussif, J. M., Alley, J., Lathwal, S., Piotrowski, M., Janiszewski, J. S., Kibbey, R. G., Alves, T. C., Dumlao, D. S., et al. (2019) · SSRN Electronic Journal · doi:10.1101/635789 · Cited by 12
Discriminative Subtyping of Lung Cancers from Histopathology Images via Contextual Deep LearningPreprint
Lengerich, B. J., Al-Shedivat, M., Alavi, A., Williams, J. A., Labbaki, S., & Xing, E. P. (2020) · medRxiv · doi:10.1101/2020.06.25.20140053 · Cited by 12
“For this investigation, we use lung cancer data available in the NCI Genomic Data Commons [55], which includes both TCGA and TCIA resources to provide multi-modal descriptions of a large number of cancer patients.”
MethodEmpirical Risk Minimization under Random Censorship: Theory and PracticePreprint
Ausset, G., Clémençon, S., & Portier, F. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1906.01908 · Cited by 12
“The performance of the IPCW approach is now investigated on the TCGA Cancer data (Grossman et al., 2016) using solely the RNA transcriptomes as informative variables.”
MethodClark, L. E., DICKINSON, A. J. G., & Lima, S. (2023) · Cells · doi:10.3390/cells12141886 · Cited by 11
“Pan-cancer genomic alterations were evaluated in TCGA data available through the Genomic Data Commons Data Portal [32].”
MethodNg, C. W., Wong, K., Lawson, B. C., Borgogno, S. F., & Mok, S. C. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-024-06007-8 · Cited by 11
German-Cortés, J., Herrero, R., Torroglosa, N., Pumarola, A., Fischer-Albiol, N., Campos-Moreno, S., Sabaté, S., Alcina, A. G., Mancilla, S., García-Lareu, B., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113616 · Cited by 11
Metadata harmonization from biological datasets with language models
Verbitsky, A., Boutet, P., & Eslami, M. (2024) · Bioinformatics Advances · doi:10.1093/bioadv/vbaf241 · Cited by 11
“…including NCIt (Golbeck et al. 2003), Cancer Data Standards Registry and Repository (caDSR) (Brady et al. 2024), Genomic Data Commons (GDC) (Grossman et al. 2016), International Classification of Diseases for Oncology (ICD-O3) [International Classification of Diseases for Oncology, 3rd…”
Reproducibility and Transparency by Design
Petyuk, V., Gatto, L., & Payne, S. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ip119.001567 · Cited by 11
“In a multi-omics project, it is now common to require that the mass spectrometry instrument files are freely shared via public repositories, which exist for genomics (10), proteomics (11), and metabolomics (12).”
BackgroundHou, X., Chen, C., Lan, X., & He, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.975787 · Cited by 11
“gov/) and presented gene mutation between high and low SIGLEC15 (cut by median value of SIGLEC15) (39).”
BackgroundLakbir, S., Lahoz, S., Cuatrecasas, M., Camps, J., Glas, R. A., Heringa, J., Meijer, G. A., Abeln, S., & Fijneman, R. J. A. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.09.034 · Cited by 11
Broad misappropriation of developmental splicing profile by cancer in multiple organs
Singh, A., Rajeevan, A., Gopalan, V., Agrawal, P., Day, C., & Hannenhalli, S. S. (2022) · Nature Communications · doi:10.1038/s41467-022-35322-1 · Cited by 11
“The public mutation calls and copy number ampli fi cations from whole exome sequencing data of human cancers are publicly available from TCGA genomics data commons portal (https://portal.gdc.cancer.gov/) 120 .”
Ontological Representation of FAIR Principles: A Blueprint for FAIRer Data Sources
Bernasconi, A., Alberto García, S., Guizzardi, G., Santos, L. O. B. D. S., & Storey, V. C. (2023) · Lecture notes in computer science · doi:10.1007/978-3-031-34560-9_16 · Cited by 11
SIGNET: transcriptome-wide causal inference for gene regulatory networks
Jiang, Z., Chen, C., Xu, Z., Wang, X., Zhang, M., & Zhang, D. (2023) · Scientific Reports · doi:10.1038/s41598-023-46295-6 · Cited by 11
“It selects genes with TPM greater than 0.1 in at least 20% of the samples and at least six reads in at least 20% of samples.”
BackgroundMethodInfluentialOh, E.-Y., Han, K., Kim, A., Kang, Y., Tae, W., Han, M.-R., & Ham, B. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02849-4 · Cited by 11
Diosmin reduces the stability of Snail and Cyclin D1 by targeting FAK to inhibit NSCLC progression
Ma, C., Dan, M., Wang, Y., Shu, C., Jiao, M., Shao, Y., Zhang, H., Li, C., Zeng, Y., Zhu, J., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156135 · Cited by 11
Is FAM19A5 an adipokine? Peripheral FAM19A5 in wild-type, FAM19A5 knockout, and LacZ knockin mice
Kwak, H., Cho, E.-H., Cho, E. B., Lee, Y.-N., Shahapal, A., Yong, H. J., Reyes‐Alcaraz, A., Jeong, Y., Lee, Y., Lee, M., et al. (2024) · Molecules and Cells · doi:10.1016/j.mocell.2024.100125 · Cited by 11
Metadata
- Authors
- Grossman, R. L., Heath, A. P., Ferretti, V., Varmus, H. E., Lowy, D. R., Kibbe, W. A., & Staudt, L. M.
- Affiliations
- Ontario Institute for Cancer Research (CA)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-09-22
- Volume
- 375
- Issue
- 12
- Pages
- 1109-1112
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC6309165
- OpenAlex
- W2521492299
- Cited by
- 1,680
- References
- 7
- Citations by year
- 2026: 111 · 2025: 141 · 2024: 192 · 2023: 223 · 2022: 231 · 2021: 238 · 2020: 190 · 2019: 171 · 2018: 114 · 2017: 64 · 2016: 5
- FWCI
- 49.40
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (Z01BC008905)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Physical Sciences › Computer Science › Information Systems › Research Data Management Practices
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Science, Research, and Medicine
- Keywords
- Genomic Data Commons, data sharing, data harmonization, precision oncology, TCGA, targets, bioinformatics pipeline, clinical data standardization, data interoperability
- MeSH terms
- DNA, Neoplasm, Humans, Neoplasms, United States, Genome, Human, National Cancer Institute (U.S.), Precision Medicine, Datasets as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.